Keyphrases
Amyotrophic Lateral Sclerosis
100%
Duchenne muscular Dystrophy
85%
Myopathy
39%
Superoxide Dismutase 1 (SOD1)
23%
Skeletal muscle
23%
Placebo
20%
Valosin-containing Protein
20%
Frontotemporal Dementia
20%
Clinical Trials
19%
Acetylcholine Receptor (AChR)
19%
Limb-girdle muscular Dystrophy
19%
Antisense Oligonucleotides
18%
Autoantibodies
18%
Spinal muscular Atrophy
17%
Prednisone
17%
Myasthenia Gravis
17%
TAR DNA-binding Protein 43 (TDP-43)
16%
Polyneuropathy
15%
Neuromuscular Disease
14%
Motor Neuron Disease
14%
Muscular Dystrophy
14%
Muscle Fiber
14%
Cerebrospinal Fluid
13%
Muscle Biopsy
13%
Dystrophin
13%
Phase II Trial
13%
Inclusion Body Myopathy
13%
Disease Progression
12%
Nerve
12%
Autophagy
12%
Multisystem Proteinopathy
12%
Neurodegenerative Diseases
12%
Central Nervous System
11%
Muscle Strength
11%
Serum IgM
11%
Axon
11%
Clinical Features
10%
Motor Neuron
10%
Paget's Disease of Bone
10%
Idiopathic Inflammatory Myopathies
10%
Inclusion Body Myositis
10%
Neuromuscular Junction
10%
Becker muscular Dystrophy
10%
Mouse Model
10%
GM1 Ganglioside
10%
Dysferlinopathy
10%
Ventral Tegmental Area
9%
C9orf72
9%
Natural History
9%
IBMPFD
9%
Gene Therapy
9%
Randomized Double-blind
8%
DNAJB6
8%
United States
8%
Corticosteroids
8%
Electrodiagnosis
8%
Denervation
8%
High Titer
8%
Neuropathy
8%
Multifocal Motor Neuropathy
8%
Peripheral Nerve
7%
Pompe Disease
7%
Placebo-controlled
7%
Demyelinating Polyneuropathy
7%
Alzheimer's Disease
7%
Peripheral Neuropathy
7%
Serum Antibody
7%
Sporadic Inclusion Body Myositis (sIBM)
7%
Ultrasound
6%
Tofersen
6%
Magnetic Resonance Imaging
6%
Quantitative Ultrasound
6%
Pathological Features
6%
Chronic Inflammatory Demyelinating Polyneuropathy
6%
Duchenne
6%
Age of Onset
6%
Randomized Placebo-controlled Trial
6%
Natural History Study
6%
Mitochondria
6%
Mitochondrium
6%
Myopathic
6%
Adverse Events
6%
Protein Aggregates
6%
Confidence Interval
5%
Lower Motor Neuron Syndrome
5%
Tolerability
5%
Onasemnogene Abeparvovec
5%
Forced Vital Capacity
5%
Muscle Pathology
5%
Motor Neuropathy
5%
Immune Response
5%
Autosomal Dominant
5%
Muscle Weakness
5%
SQSTM1
5%
Spinal Cord
5%
Randomized Controlled Trial
5%
Dermatomyositis
5%
Electrical Impedance Myography
5%
Charcot-Marie-Tooth Disease
5%
Timed Tests
5%
Neuroscience
Amyotrophic Lateral Sclerosis
66%
Muscle Disorder
52%
Muscular Dystrophy
48%
Neuropathy
35%
Polyneuropathy
19%
Axon
18%
Immunoglobulin M
17%
Myositis
15%
Cholinergic Receptor
15%
Autoantibodies
14%
Myasthenia gravis
13%
Neurodegenerative Disorder
12%
Skeletal Muscle
12%
Frontotemporal Dementia
12%
Antisense Oligonucleotide
11%
Valosin-Containing Protein
10%
Ventral Tegmental Area
10%
Copper Zinc Superoxide Dismutase
10%
Neuromuscular
10%
Neuromuscular Junction
9%
Alzheimer's Disease
9%
Peripheral Nerve
9%
Central Nervous System
8%
Placebo
8%
In Vivo
8%
Exon
7%
Electrodiagnosis
7%
Denervation
7%
Receptor
6%
Prion Protein
6%
Motor Neuron Disease
6%
Lower Motor Neuron
6%
Magnetic Resonance Imaging
6%
Dystrophin
6%
Prednisone
6%
Behavior (Neuroscience)
6%
Neuromuscular Disorder
5%
Synapse
5%
Staining Technique
5%
Messenger RNA
5%
Autophagy
5%
In Vitro
5%
TAR DNA Binding Protein
5%
Encephalitis
5%
SOD1
5%
Ischemia
5%
Blood Plasma
5%
Creatine Kinase
5%
Medicine and Dentistry
Duchenne Muscular Dystrophy
48%
Amyotrophic Lateral Sclerosis
33%
Myopathy
29%
Diseases
28%
Weakness
21%
Skeletal Muscle
18%
Placebo
17%
Clinical Trial
16%
Neuropathy
11%
Spinal Muscular Atrophy
11%
Muscular Dystrophy
11%
Muscle Biopsy
10%
Magnetic Resonance Imaging
10%
Polyneuropathy
9%
Upper Limb
9%
Adverse Event
9%
Electrodiagnosis
9%
Muscle Disease
8%
Disease
8%
Immunoglobulin M
8%
Neuromuscular Disease
8%
Dystrophin
8%
Exon
8%
Limb Girdle Muscular Dystrophy
7%
Muscle Weakness
7%
Cerebrospinal Fluid
7%
Dysferlinopathy
6%
Valosin Containing Protein
6%
Limb
6%
Disease Exacerbation
6%
Muscle Strength
6%
Antisense Oligonucleotide
6%
Prednisone
6%
Becker Muscular Dystrophy
6%
Denervation
6%
Tau
5%
Autophagy
5%
Dystrophy
5%
Multifocal Motor Neuropathy
5%
Inclusion Body Myositis
5%
Glycogen Storage Disease Type II
5%
Myography
5%
Cholinergic Receptor
5%
Gene Therapy
5%
Neuromuscular Disorder
5%
Creatine Kinase
5%
Biological Marker
5%
Personalized Medicine
5%
Ultrasonography of Muscle
5%
Axon
5%
Onasemnogene Abeparvovec
5%